Biodistribution and breast tumor uptake of 16α-[18F]-fluoro-17 β- estradiol in rat

Masayuki Sasaki, Toshimitsu Fukumura, Yasuo Kuwabara, Tsuyoshi Yoshida, Makoto Nakagawa, Yuichi Ichiya, Kouji Masuda

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)


To evaluate the usefulness of 16α-[18F]-fluoro-17β-estradiol (FES) for the assessment of estrogen receptor (ER), we examined the tissue distribution and kinetics Of FES in immature female Sprague-Dawley rats and then examined FES uptake in rat breast tumors induced by 7, 12- dimethylbenz(a) anthracene (DMBA). The FES uptake by the uterus, an ER-rich tissue, was highly selective and it was 3.34 ± 0.79%ID/g at 60 minutes and 1.57 ± 0.57%ID/g at 120 minutes after injection. The FES uptakes in ER- negative tissues were 0.12 ± 0.05%ID/g or less and 0.05 ± 0.03%ID/g or less, respectively. Coadministration of unlabeled β-estradiol showed marked depression of uterine FES uptake. The FES uptake by rat breast tumors was 0.14 ± 0.06%ID/g at 60 min and 0.12 ± 0.09%ID/g at 120 min. The FES uptake by rat breast tumors correlated with the ER concentration (r = 0.45, p < 0.05). In conclusion, these results suggest that the FES uptake by tissue is mainly ER mediated and FES is thus useful for detecting ER positive breast tumors.

Original languageEnglish
Pages (from-to)127-130
Number of pages4
JournalAnnals of Nuclear Medicine
Issue number2
Publication statusPublished - Apr 2000

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Biodistribution and breast tumor uptake of 16α-[18F]-fluoro-17 β- estradiol in rat'. Together they form a unique fingerprint.

Cite this